The official cancer numbers are in, and they’re alarming.
According to theNational Cancer Institute’s latest SEER data release,cancer incidence rates among Americans under age 50 jumped 6.4% between 2021 and 2023— with colon/rectal cancer (+19.4%), brain tumors (+19.5%), small intestine (+15.5%), ovarian (+12.8%), stomach (+7.3%), and breast cancer (+3.6%) all showing very alarming signals — right in the middle of the mass mRNA injection campaigns.
Here are the actual observed rates straight from the SEER explorer:
Click here for an enlarged view
Click here for an enlarged view
Early-onset cancers (under 50) were already rising slowly for years, but the post-2021 acceleration is unmistakable — and it lines up precisely with the rollout of mass mRNA shots starting in late 2020/early 2021.
This latest SEER data corroborates several major independent analyses pointing in the same direction:
In a30-month population-wide analysis of 296,015 residentsin Pescara Province, Italy, individuals who received at least one dose of a COVID-19 vaccine showed a 23% higher likelihood of hospitalization for cancer of any site (HR: 1.23; 95% CI: 1.11-1.37) compared to the unvaccinated. Risks were particularly elevated for colorectal (HR: 1.34), breast (HR: 1.54), and bladder cancers (HR: 1.62)
Click here for an enlarged view
A separatelarge-scale South Korean studyinvolving over 8.4 million individuals found that COVID-19 vaccination was associated with increased 1-year risks for 6 major cancers: thyroid (HR: 1.35), gastric (HR: 1.34), colorectal (HR: 1.28), lung (HR: 1.53), breast (HR: 1.20), and prostate (HR: 1.69).
Source: Global Research
